Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
gc012f car-t cell
Multiple Sclerosis
Daishi Tian
Early P1
C
(34)
Human Cd19 Targeted Dash Car-T Cells
B-Cell Acute Lymphoblastic Leukemia
Hrain Biotechnology Co., Ltd.
Early P1
C
(34)
il-15 enhanced engineered nk cells
Neoplasm
Genovn Therapeutics (Suzhou) Co., Ltd.
Early P1
C
(34)
im92 car-t cells
Gastric Cancer
Beijing Immunochina Medical Science & Technology Co., Ltd.
Early P1
C
(34)
Ink Cells
Small Cell Lung Carcinoma
Guangzhou Ruixin Biotechnological Co., LTD
Early P1
C
(34)
Metabolically Armed Cd19 Car-T Cells
B-Cell Acute Lymphoblastic Leukemia
Anhui Provincial Hospital
Early P1
C
(34)
Metabolically Armed Gpc3 Car-T Cells
Hepatocellular Carcinoma
Zhejiang University
Early P1
C
(34)
nk042
Multiple Sclerosis
The Affiliated Hospital of Xuzhou Medical University
Early P1
C
(34)
rd14-01 cell
Follicular Lymphoma
He Huang
Early P1
C
(34)
rd14-01 cell
Mantle Cell Lymphoma
He Huang
Early P1
C
(34)
Universal Cd19 Car-T
Myasthenia Gravis
Xuanwu Hospital, Beijing
Early P1
C
(34)
Yfmt
Metastatic Malignant Neoplasm In The Colon
The First Affiliated Hospital of Xiamen University
Early P1
C
(34)
αpd1/ctla4-msln-car t cells
Neoplasm
Shanghai Cell Therapy Group Co.,Ltd
Early P1
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Fallopian Tube Cancer
Roswell Park Cancer Institute
P1/2
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Ovarian Cancer
Roswell Park Cancer Institute
P1/2
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Fallopian Tube Carcinoma
Roswell Park Cancer Institute
P1/2
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Ovarian Carcinoma
Roswell Park Cancer Institute
P1/2
C
(34)
Alpha-Type-1 Polarized Dendritic Cells
Primary Peritoneal Carcinoma
Roswell Park Cancer Institute
P1/2
C
(34)
Autologous Cd19/Cd20 Dual-Target Car-T Module
T-Cell Acute Lymphoblastic Leukemia
Beijing Biotech
P1/2
C
(34)
cd19-ucart
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
University Hospital Heidelberg
P1/2
C
(34)
Dual-Target Car-Nk Cells
Triple-Negative Breast Carcinoma
Beijing Biotech
P1/2
C
(34)
gpc3-car-t cells
Hepatocellular Carcinoma
RenJi Hospital
P1/2
C
(34)
vor33
Myelodysplastic Syndrome
Vor Biopharma
P1/2
C
(34)
Bcma-Cd19 Ccar T Cells
Immunoglobulin G4-Related Sclerosing Disease
Peking University People's Hospital
P2
C
(33)
19ucart
Lymphoma
YANRU WANG
P1
C
(33)
Showing 2476 to 2500 of 3,186 assets
Previous
Page 100 of 128
Next
